Long-term follow up after transcatheter closure of atrial septal defect and patent foramen ovale in adults
Abstract
Background: The aim of our study was to define long-term electrocardiographic and echocardiographic changes and complications after transcatheter closure of atrial septal defect and patent foramen ovale in adults.
Methods: The clinical, electrocardiographic and echocardiographic follow-up of 137 consecutive patients that underwent transcatheter closure of atrial septal defect (51 patients) or patent foramen ovale (86 patients) in a 10-year period was analyzed retrospectively.
Results: In the patent foramen ovale group, we observed no significant postprocedural changes. There were no changes in heart rate, heart rhythm and PR or QRS duration in both groups. In the atrial septal defect group, we observed a leftward shift in the heart axis (p = 0.017), a decrease in the estimated systolic pulmonary artery pressure (p = 0.024), decreased tricuspid early diastolic flow velocity (p = 0.002), a decrease in the right chamber dimensions (p = 0.0004) and interventricular septal movement normalization (p < 0.0001). Most of the complications were mild and occurred early after the procedure. Three early serious complications were documented.
Conclusions: No electrocardiographic or echocardiographic changes occurred after patent foramen ovale closure. Atrial septal defect closure is related to significant early morphological and hemodynamic improvement. Postprocedural complications are usually early and mild but serious late complications can occur. For that reason, long-term follow up is recommended in these patients.
Downloads
References
Gatzoulis MA, Swan L, Therrien J, Pantely GA. Adult congenital heart disease: a practical guide. Blackwell publishing, Oxford (UK), 2005.
King TD, Thompson SL, Steiner C, Mils NL. Secundum atrial septal defects: nonoperative closure during cardiac catheterization. JAMA 1976; 235: 2506–2509.
McMahon CJ, Feltes TF, Fraley JK, Bricker JT, Grifka RG, Tortoriello TA, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 2002; 87: 256–9.
Mareedu RK, Shah MS, Mesa JE, McCauley CS. Percutaneous closure of patent foramen ovale: a case series and literature review. Clin Med Res 2007; 4: 218–226.
Lock JE. Patent foramen ovale is indicted, but the case hasn’t gone to trial. Circulation 2000; 101: 838.
Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012; 366: 991–9.
van de Wyngaert F, Kefer J, Hermans C, Ovaert C, Pasquet A, Beguin C, et al. Absence of recurrent stroke after percutaneous closure of patent foramen ovale despite residual right-to-left cardiac shunt assessed by transcranial Doppler. Arch Cardiovasc Dis 2008; 101 (7–8): 435–41.
Cifarelli A, Musto C, Parma A, Pandolfi C, Pucci E, Fiorilli R, et al. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism. Int J Cardiol 2010; 141(3): 304–10.
Majunke N, Bialkowski J, Wilson N, Szkutnik M, Kusa J, Baranowski A, et al. Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol 2009; 103(4): 550–4.
Moiduddin N, Cheatham JP, Hoffman TM, Phillips AB, Kovalchin JP. Amplatzer septal occluder associated with late pulmonary venous obstruction requiring surgical removal with acquired aorta to left atrial fistula. Am J Cardiol 2009; 103: 1039–1040.
Kazmi T, Sadiq M, Asif-ur-Rehman, Hyder N, Latif F. Intermediate and long-term outcome of patients after device closure of ASD with special reference to complications. J Ayub Med Coll Abbotabad 2009; 21: 117–121.
Li W, Han W, Yu C, Zhang C, Tu Z, Wu S, et al. Severe mitral insufficiency after transcatheter atrial septal defect closure with the Amplatzer septal occluder: a device-related complication. J Card Surg 2009; 24(6): 672–4.
Piatkowski R, Kochanowski J, Scislo P, Kochman J, Opolski G. Dislocation of Amplatzer septal occluder device after closure of secundum atrial septal defect. J Am Soc Echocardiogr 2010; 23: 1007.e1–2.
Al-Anani SJ, Weber H, Hijazi ZM. Atrioventricular block after transcatheter ASD closure using the Amplatzer septal occluder: risk factors an recommendations. Catheter Cardiovasc Interv 2010; 75: 767–772.
Fischer D, Haentjes J, Klein G, Schieffer B, Drexler H, Meyer GP, et al. Transcatheer closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer occluder device. J Interv Cardiol 2011; 24(1): 85–91.
Luermans JG, Post MC, ten Berg JM, Plokker HW, Suttorp MJ. Long-term outcome of percutaneous closure of secundum-type atrial septal defects in adults. EuroIntervention 2010; 6: 604–610.
Yalonetsky S, Lorber A. Comparative changes of pulmonary artery pressure values and tricuspid valve regurgitation following transcatheter atrial septal defect closure in adults and the elderly. Congenit Heart Dis 2009; 4: 17–20.
Yong G, Khairy P, De Guise P, Dore A, Marcotte F, Mercier LA, et al. Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interv 2009; 2(5): 455–62.
Jategaonkar S, Scholtz W, Schmidt H, Fassbender D, Horstkotte D. Cardiac remodelling and effects on exercise capacity after interventional closure of atrial septal defects in different adult age groups. Clin Res Cardiol 2010; 99: 183–191.
Mainzer G, Braver Y, Khoury A, Schwartz Y, Galenter-Yaniv L, Yalonetsky S, et al. Morphologic, mechanical, conductive, and hemodynamic changes following transcatheter closure of atrial septal defect. Congenit Heart Dis 2010; 5(1): 25–31.
Khan AA, Than JL, Li W, Dimopoulus K, Spence MS, Chow P, et al. The impact of transcatheter atrial septal defect closure in the older population: a prospective study. JACC Cardiovasc Interv 2010; 3(3): 276–81.
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440–63.
Johnson JN, Marquardt ML, Ackerman MJ, Asirvatham SJ, Reeder GS, Cabalka AK, et al. Electrophysiologic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure. Catheter Cardiovasc Interv 2011; 78(2): 254–61.
Hill SL, Berul CI, Patel HT, Rhodes J, Supran SE, Cao QL, et al. Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J Interv Card Electrophysiol 2000; 4(3): 469–74.
Dhillon R, Josen M, Henein M, Redington A. Transcatheter closure of atrial septal defect preserves right ventricular function. Heart 2002; 87: 461–465.
Thomson JDR, Aburawi EH, Watterson KG, Van Doorn C, Gibbs JL. Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost. Heart 2002; 87: 466–469.
Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63(4): 496–502.
Sarris GE, Kirvassilis G, Zavaropoulus P, Belli E, Berggren H, Carrel T, et al. Surgery for complications of trans-catheter closure of atrial septal defects: a multi-insitutional study from the European Congenital Heart Surgeons Association. Eur J Cardiothorac Surg 2010; 37: 1285–90.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
